CapWealth Advisors LLC Has $1.55 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

CapWealth Advisors LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,165 shares of the company’s stock after selling 402 shares during the period. CapWealth Advisors LLC’s holdings in HCA Healthcare were worth $1,550,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. MML Investors Services LLC raised its stake in HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after acquiring an additional 4,285 shares in the last quarter. Meritage Group LP bought a new position in HCA Healthcare during the 3rd quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $18,044,000. Alpha DNA Investment Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at $869,000. Finally, NRI Wealth Management LC acquired a new position in HCA Healthcare during the 4th quarter worth about $2,896,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 1.8 %

HCA Healthcare stock opened at $316.18 on Friday. The company has a fifty day simple moving average of $313.30 and a 200 day simple moving average of $352.55. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a market cap of $80.09 billion, a P/E ratio of 14.39, a price-to-earnings-growth ratio of 1.11 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is 12.02%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on HCA shares. Morgan Stanley reduced their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Oppenheimer increased their price target on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Royal Bank of Canada lowered their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.